WP1 co-leads (Sarah Garner, NICE & Mike Chambers, GSK), with support from Wim Goettsch (ZIN), hosted a panel session on collaborative approaches to developing a framework for the use of Real World Data (RWD) at the HTAi Conference in Washington, USA (16-20 June).
The session was well attended and whilst there was debate about the role of RWD, there was agreement that methods need to be developed and issues resolved. There was recognition that RWD encompassed a range of study designs and that in line with evidence based medicine principles studies had to be appraised on their scientific methods.
Conference themes were (1) Optimizing outcomes: opportunities for HTA in Times of economic uncertainty, (2) Putting the patient and public in the centre, (3) Is HTA stifling or enhancing innovation? and (4) HTA and adaptive pathways to patients. In connection with theme (4) the proceedings of the HTAi Policy Forum on adaptive pathways has now been published on-line in the HTAi journal (Husereau et al. Int J Tech Ass in Health care, 2014;30(3) – first view article).